Advancing Glaucoma Medical Therapies, Making MIGS Treatment Decisions, and Combining Procedures in the Context of Cataract Surgery

Be the first to review this product

Availability: In stock

$0.00
    OR

    Quick Overview

    This activity is supported by educational grants from Aerie Pharmaceuticals, Santen Pharmaceuticals, Allergan, Bausch + Lomb, Glaukos Corporation, and Ivantis.
    Credits: By completing this activity you will earn 1.0 AMA PRA Category 1 Credit™.
    Activity Expiration Date: February 29, 2020

    Advancing Glaucoma Medical Therapies, Making MIGS Treatment Decisions, and Combining Procedures in the Context of Cataract Surgery

    Double click on above image to view full picture

    Zoom Out
    Zoom In

    More Views

    Details

    Description

    Enjoy this 60-minute CME activity in which a panel of experts discuss a range of soltuions for glaucoma and combined procedures. Topics include glaucoma medical therapies, glaucoma in the context of cataract surgery, and the impact of non-compliance on treatment decisions.

    CME Information

    This activity is supported by educational grants from Aerie Pharmaceuticals, Santen Pharmaceuticals, Allergan, Bausch + Lomb, Glaukos Corporation, and Ivantis.

    Credits: By completing this activity you will earn 1.0 AMA PRA Category 1 Credit™.

    Activity Expiration Date: February 29, 2020

    Faculty: Doublas J. Rhee, MD; Nathan M. Radcliffe, MD; Cathleen M. McCabe, MD; Marlene R. Moster, MD

    Learning Objectives

    Ophthalmologists who attend this course will:

    • Describe new and emerging options in glaucoma medical therapy, laser treatment, and MIGS
    • Determine how best to apply therapeutic options and treatment decisions for the patient who is (or is suspected to be) noncompliant with topical drops
    • Use scientific evidence and diagnostic information to guide timing and combination of procedures for reduction of IOP in the context of cataract surgery